Literature DB >> 31802207

A positive Helicobacter pylori test is associated with low spondylarthritis incidence in a Danish historical cohort study.

Lars E Bartels1, Alma B Pedersen2, Nickolaj R Kristensen2, Hendrik Vilstrup3, Kristian Stengaard-Pedersen4, Jens F Dahlerup3.   

Abstract

Ankylosing spondylitis (AS) and undifferentiated spondylarthritis (uSpA) are related inflammatory diseases affecting the spine and joints with infections among possible etiological factors. Helicobacter pylori (H. pylori) may affect the development of inflammatory diseases. Thus, we hypothesized that H. pylori infection affects AS and uSpA development. This cohort study was performed in Denmark with 56,000 patients from primary health care centers who were enrolled when a UBT was performed. They were followed for a median time of 8 years. From nationwide administrative registries, we extracted personal, diagnostic, and treatment information. Prevalence at time of UBT was studied on enrollment using logistic regression and incidence in the follow-up time of 8 years after UBT was studied using Cox regression, comparing H. pylori positive and H. pylori negative patients and adjusting for confounding variables. The prevalence of AS at the time of the UBT was higher among H. pylori positive individuals (OR = 2.00, CI 1.17-3.41), but likely to be linked to confounding as trends disappeared when stratifying for country of birth. The incidence of AS after UBT was lower for individuals who were previously H. pylori positive (OR = 0.23, CI 0.06-0.93). A similar phenomenon was observed for uSpA. As a novel finding, after UBT, the previously H. pylori infected individuals had lower risk of developing AS and uSpA compared to non-infected. This finding may be caused by etiological effects of previous H. pylori infection or unknown confounders. This suggests that H. pylori may somehow be positively involved in the pathogenesis of AS and uSpA.

Entities:  

Keywords:  Ankylosing spondylitis; Epidemiology; Helicobacter pylori; Spondylarthritis

Mesh:

Year:  2019        PMID: 31802207     DOI: 10.1007/s00296-019-04487-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  36 in total

Review 1.  Diagnosis and epidemiology of Helicobacter pylori infection.

Authors:  Xavier Calvet; María-José Ramírez Lázaro; Philippe Lehours; Francis Mégraud
Journal:  Helicobacter       Date:  2013-09       Impact factor: 5.753

2.  First-time urea breath tests performed at home by 36,629 patients: a study of Helicobacter pylori prevalence in primary care.

Authors:  Søren Dahlerup; Rikke Charlotte Andersen; Birgitte Sperling Wilms Nielsen; Inger Schjødt; Lisbet Ambrosius Christensen; Lars Ulrik Gerdes; Jens Frederik Dahlerup
Journal:  Helicobacter       Date:  2011-12       Impact factor: 5.753

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

Review 4.  Imbalance of Gastrointestinal Microbiota in the Pathogenesis of Helicobacter pylori-Associated Diseases.

Authors:  Cong He; Zhen Yang; Nonghua Lu
Journal:  Helicobacter       Date:  2016-02-15       Impact factor: 5.753

Review 5.  Diagnosis and treatment of Helicobacter pylori infection.

Authors:  Peter Bytzer; Jens Frederik Dahlerup; Jens Ravn Eriksen; Dorte Ejg Jarbøl; Steffen Rosenstock; Signe Wildt
Journal:  Dan Med Bull       Date:  2011-04

Review 6.  Axial spondyloarthritis.

Authors:  Joachim Sieper; Denis Poddubnyy
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

7.  Helicobacter pylori infection is not associated with rheumatoid arthritis.

Authors:  L E Bartels; A B Pedersen; N R Kristensen; P Jepsen; H Vilstrup; K Stengaard-Pedersen; J F Dahlerup
Journal:  Scand J Rheumatol       Date:  2018-07-17       Impact factor: 3.641

8.  Ankylosing Spondylitis and Axial Spondyloarthritis in Patients With Long-term Inflammatory Bowel Disease: Results From 20 Years of Follow-up in the IBSEN Study.

Authors:  Alvilde M Ossum; Øyvind Palm; Aida Kapic Lunder; Milada Cvancarova; Hasan Banitalebi; Anne Negård; Ole Høie; Magne Henriksen; Bjørn A Moum; Marte Lie Høivik
Journal:  J Crohns Colitis       Date:  2018-01-05       Impact factor: 9.071

9.  Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions.

Authors:  Sigrun Alba Johannesdottir; Erzsébet Horváth-Puhó; Vera Ehrenstein; Morten Schmidt; Lars Pedersen; Henrik Toft Sørensen
Journal:  Clin Epidemiol       Date:  2012-11-12       Impact factor: 4.790

Review 10.  The immunomodulatory properties of Helicobacter pylori confer protection against allergic and chronic inflammatory disorders.

Authors:  Isabelle C Arnold; Iris Hitzler; Anne Müller
Journal:  Front Cell Infect Microbiol       Date:  2012-02-16       Impact factor: 5.293

View more
  2 in total

1.  Exploration of Potential Ewing Sarcoma Drugs from FDA-Approved Pharmaceuticals through Computational Drug Repositioning, Pharmacogenomics, Molecular Docking, and MD Simulation Studies.

Authors:  Mubashir Hassan; Muhammad Yasir; Saba Shahzadi; Andrzej Kloczkowski
Journal:  ACS Omega       Date:  2022-06-01

2.  Association Between Infections and Risk of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis.

Authors:  Xiao Zhang; Zhe Sun; Aihong Zhou; Lei Tao; Yingxin Chen; Xinyu Shi; Jia Yin; Zheng Sun; Guoyong Ding
Journal:  Front Immunol       Date:  2021-10-22       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.